Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Sep;76(3):919–923. doi: 10.1172/JCI112090

Effects of dichloroacetate in the treatment of hypoxic lactic acidosis in dogs.

H Graf, W Leach, A I Arieff
PMCID: PMC423954  PMID: 4044835

Abstract

The metabolic and systemic effects of dichloroacetate (DCA) in the treatment of hypoxic lactic acidosis were evaluated in the dog and compared with the infusion of equal quantities of volume and sodium. Hypoxic lactic acidosis was induced by ventilating dogs with an hypoxic gas mixture of 8% oxygen and 92% nitrogen, resulting in arterial PO2 of less than 30 mmHg, pH below 7.20, bicarbonate less than 15 mM, and lactate greater than 7 mM. After, the development of hypoxic lactic acidosis dogs were treated for 60 min with either DCA as sodium salt or NaCl at equal infusions of volume and sodium. Dogs treated with DCA showed a significant increase of arterial blood pH and bicarbonate, and steady levels of lactate, whereas NaCl resulted in further declines of blood pH and bicarbonate, and rising blood lactate levels. Overall lactate production decreased during therapy with either regimen, but hepatic lactate extraction increased significantly with DCA, while it remained unchanged with NaCl. Tissue lactate levels in liver and skeletal muscle decreased significantly with DCA treatment but were unchanged with NaCl. Additionally, an increase in muscle intracellular pH was observed only in DCA treated dogs. A possible mechanism for the observed actions of DCA might be related to a significant increase in oxygen delivery to tissues. Such an effect was found with DCA administration, but was not observed with NaCl therapy. In conclusion, DCA therapy in hypoxic lactic acidosis has beneficial systemic effects compared with therapy with NaCl. DCA administration is accompanied by increases of blood pH and bicarbonate, a decrease in lactate production, and enhanced liver lactate extraction, and a lowering of tissue lactate levels.

Full text

PDF
919

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arieff A. I., Park R., Leach W. J., Lazarowitz V. C. Pathophysiology of experimental lactic acidosis in dogs. Am J Physiol. 1980 Aug;239(2):F135–F142. doi: 10.1152/ajprenal.1980.239.2.F135. [DOI] [PubMed] [Google Scholar]
  2. BRODER G., WEIL M. H. EXCESS LACTATE: AN INDEX OF REVERSIBILITY OF SHOCK IN HUMAN PATIENTS. Science. 1964 Mar 27;143(3613):1457–1459. doi: 10.1126/science.143.3613.1457. [DOI] [PubMed] [Google Scholar]
  3. Bellingham A. J., Detter J. C., Lenfant C. Regulatory mechanisms of hemoglobin oxygen affinity in acidosis and alkalosis. J Clin Invest. 1971 Mar;50(3):700–706. doi: 10.1172/JCI106540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crabb D. W., Yount E. A., Harris R. A. The metabolic effects of dichloroacetate. Metabolism. 1981 Oct;30(10):1024–1039. doi: 10.1016/0026-0495(81)90105-0. [DOI] [PubMed] [Google Scholar]
  5. Diamond M. P., Rollings R. C., Erlendson L., Williams P. E., Lacy W. W., Rabin D., Cherrington A. D. Dichloroacetate--its in vivo effects on carbohydrate metabolism in the conscious dog. Diabetes. 1980 Sep;29(9):702–709. doi: 10.2337/diab.29.9.702. [DOI] [PubMed] [Google Scholar]
  6. Graf H., Leach W., Arieff A. I. Evidence for a detrimental effect of bicarbonate therapy in hypoxic lactic acidosis. Science. 1985 Feb 15;227(4688):754–756. doi: 10.1126/science.3969564. [DOI] [PubMed] [Google Scholar]
  7. Kilmartin J. V. Interaction of haemoglobin with protons, CO2 and 2,3-diphosphoglycerate. Br Med Bull. 1976 Sep;32(3):209–212. doi: 10.1093/oxfordjournals.bmb.a071364. [DOI] [PubMed] [Google Scholar]
  8. Loubatieres A., Valette G., Ribes G., Loubatieres-Mariani M. M., Rondot A. M. Dichloroacetate de sodium: son application a la thérapeutique des hyperlactatémies expérimentales. Diabete Metab. 1978 Mar;4(1):5–11. [PubMed] [Google Scholar]
  9. Loubatières A. L., Ribes G., Valette G. Pharmacological agents and acute experimental hyperlataemia in the dog [proceedings]. Br J Pharmacol. 1976 Nov;58(3):429P–429P. [PMC free article] [PubMed] [Google Scholar]
  10. Park R., Arieff A. I. Treatment of lactic acidosis with dichloroacetate in dogs. J Clin Invest. 1982 Oct;70(4):853–862. doi: 10.1172/JCI110682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Park R., Leach W. J., Arieff A. I. Determination of liver intracellular pH in vivo and its homeostasis in acute acidosis and alkalosis. Am J Physiol. 1979 Mar;236(3):F240–F245. doi: 10.1152/ajprenal.1979.236.3.F240. [DOI] [PubMed] [Google Scholar]
  12. Park R., Radosevich P. R., Leach W. J., Seto P., Arieff A. I. Metabolic effects of dichloroacetate in diabetic dogs. Am J Physiol. 1983 Jul;245(1):E94–101. doi: 10.1152/ajpendo.1983.245.1.E94. [DOI] [PubMed] [Google Scholar]
  13. Patel T. B., Olson M. S. Regulation of pyruvate dehydrogenase complex in ischemic rat heart. Am J Physiol. 1984 Jun;246(6 Pt 2):H858–H864. doi: 10.1152/ajpheart.1984.246.6.H858. [DOI] [PubMed] [Google Scholar]
  14. Stacpoole P. W., Harman E. M., Curry S. H., Baumgartner T. G., Misbin R. I. Treatment of lactic acidosis with dichloroacetate. N Engl J Med. 1983 Aug 18;309(7):390–396. doi: 10.1056/NEJM198308183090702. [DOI] [PubMed] [Google Scholar]
  15. Tyuma I. The Bohr effect and the Haldane effect in human hemoglobin. Jpn J Physiol. 1984;34(2):205–216. doi: 10.2170/jjphysiol.34.205. [DOI] [PubMed] [Google Scholar]
  16. Waskell L. A study of the mutagenicity of anesthetics and their metabolites. Mutat Res. 1978 May;57(2):141–153. doi: 10.1016/0027-5107(78)90261-0. [DOI] [PubMed] [Google Scholar]
  17. Whitehouse S., Cooper R. H., Randle P. J. Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem J. 1974 Sep;141(3):761–774. doi: 10.1042/bj1410761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Whitehouse S., Randle P. J. Activation of pyruvate dehydrogenase in perfused rat heart by dichloroacetate (Short Communication). Biochem J. 1973 Jun;134(2):651–653. doi: 10.1042/bj1340651. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES